Argent to retain ownership of existing and future CannEpil IP and receive 15% royalty on Splash Beverage global CannEpil ...
It’s another day of mixed signals on the market, with info tech continuing to forge ahead as resource stocks languish.
Splash Beverage Group, Inc. (NYSE American: SBEV) today announced that it has entered into an exclusive global licensing agreement with Argent BioPharma Limited (ASX/LSE: RGT) for CannEpil®, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results